These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25047743)
21. Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma. Eckert AW; Horter S; Bethmann D; Kotrba J; Kaune T; Rot S; Bache M; Bilkenroth U; Reich W; Greither T; Wickenhauser C; Vordermark D; Taubert H; Kappler M Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654595 [TBL] [Abstract][Full Text] [Related]
22. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections. Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150 [TBL] [Abstract][Full Text] [Related]
23. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ; Li JR; Li ZB Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564 [TBL] [Abstract][Full Text] [Related]
24. Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade. Liu J; Cao W; Chen W; Xu L; Zhang C J Oral Pathol Med; 2015 Feb; 44(2):109-14. PubMed ID: 25060050 [TBL] [Abstract][Full Text] [Related]
26. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation. Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326 [TBL] [Abstract][Full Text] [Related]
27. Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan. Huang TT; Chen JY; Tseng CE; Su YC; Ho HC; Lee MS; Chang CT; Wong YK; Chen HR J Formos Med Assoc; 2010 May; 109(5):326-37. PubMed ID: 20497865 [TBL] [Abstract][Full Text] [Related]
28. GSTP1 c.341C>T gene polymorphism increases the risk of oral squamous cell carcinoma. Rajesh D; Balakrishna S; Azeem Mohiyuddin SM; Suresh TN; Moideen Kutty AV Mutat Res Genet Toxicol Environ Mutagen; 2018 Jul; 831():45-49. PubMed ID: 29875076 [TBL] [Abstract][Full Text] [Related]
29. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601 [TBL] [Abstract][Full Text] [Related]
30. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. Hsiao YC; Lin SY; Chien KY; Chen SF; Wu CC; Chang YT; Chi LM; Chu LJ; Chiang WF; Chien CY; Chang KP; Chang YS; Yu JS Anal Chim Acta; 2020 Mar; 1100():118-130. PubMed ID: 31987131 [TBL] [Abstract][Full Text] [Related]
31. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes. Ranganathan PN; Whalen R; Boyer TD Biochem J; 2005 Mar; 386(Pt 3):525-33. PubMed ID: 15471539 [TBL] [Abstract][Full Text] [Related]
33. Plasma glutathione S-transferase P1-1 levels in patients with head and neck squamous cell carcinoma. Oude Ophuis MB; Mulder TP; Peters WH; Manni JJ Cancer; 1998 Jun; 82(12):2434-8. PubMed ID: 9635537 [TBL] [Abstract][Full Text] [Related]
34. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC). Mutallip M; Nohata N; Hanazawa T; Kikkawa N; Horiguchi S; Fujimura L; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N Int J Mol Med; 2011 Mar; 27(3):345-52. PubMed ID: 21181092 [TBL] [Abstract][Full Text] [Related]
35. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Shintani S; Hamakawa H; Ueyama Y; Hatori M; Toyoshima T Int J Oral Maxillofac Surg; 2010 Jan; 39(1):68-74. PubMed ID: 19896329 [TBL] [Abstract][Full Text] [Related]
36. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis. Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054 [TBL] [Abstract][Full Text] [Related]
37. Expression of MMP-1 in histopathological different grades of oral squamous cell carcinoma and in normal buccal mucosa - an immunohistochemical study. George A; Ranganathan K; Rao UK Cancer Biomark; 2010; 7(6):275-83. PubMed ID: 21694466 [TBL] [Abstract][Full Text] [Related]
38. Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression. Su CW; Su BF; Chiang WL; Yang SF; Chen MK; Lin CW Int J Med Sci; 2017; 14(1):37-44. PubMed ID: 28138307 [TBL] [Abstract][Full Text] [Related]
39. A low Dicer expression is associated with resistance to 5-FU-based chemoradiotherapy and a shorter overall survival in patients with oral squamous cell carcinoma. Kawahara K; Nakayama H; Nagata M; Yoshida R; Hirosue A; Tanaka T; Nakagawa Y; Matsuoka Y; Kojima T; Takamune Y; Yoshitake Y; Hiraki A; Shinohara M J Oral Pathol Med; 2014 May; 43(5):350-6. PubMed ID: 24325353 [TBL] [Abstract][Full Text] [Related]